You know what's pretty similar to monkeys? Humans.
Just how big a deal they are, though, is debatable.
CRISPR-focused companies saw their shares fall sharply following the studies' release.
If it works, the treatment could go a long way towards improving the lives of people with sickle cell disease.
Newly-engineered, increased-yield rice would be allowed under updated USDA rules.
We need to become a little less human.
The kit takes the guesswork out of self-diagnosis.
A new CRISPR tool does what CRISPR-Cas9 can't.
Gluten-free wheat, bigger tomatoes, non-browning mushrooms, sliding into your grocery store shelves.
If people were convinced CRISPR is dangerous, that article was (inaccurate, now-retracted) "proof."
Over 350,000 people subscribe to our newsletter.
Sign in to join the conversation.